Pacific Biosciences of California, Inc. with ticker code (PACB) have now 10 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 17 and 12 suggesting an average Analsyt target price of $13.80. Given that the stocks previous close was at $12.67 this is indicating there is a potential upside of 8.9%. Also worth taking note is the 50 day moving average now sits at $10.80 and the 200 moving average now moves to $9.07. The total market capitalization for the company now stands at 3.26B. The current stock price for Coherent Corp. is currently 13.06 USD
The potential market cap would be $3,554,645,363 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 0.58 and a -9.83% return on assets.
